Biomarkers in heart failure: a clinical review.

Abstract:

:The diagnosis and management of heart failure remains challenging despite considerable clinical advances in recent decades. With greater understanding of the pathophysiology of this complex syndrome, a large number of candidate biomarkers have emerged and duly received scientific and clinical attention. These are frequently a measure of the degree of pathophysiological derangement or counter-regulatory processes occurring in heart failure and include biomarkers of neurohormonal activation, myocyte necrosis and myocardial remodelling amongst others. As such they may serve as an indicator of the presence, severity and possibly therapeutic response of the heart failure syndrome and may complement conventional clinical measurements and acumen. This may in turn lead to tangible clinical benefits and the targeting of intensified and often costly therapies to those most at risk. This article reviews and summarises the most extensively investigated biomarkers currently available, with an emphasis on clinical applicability and discusses the future evaluation of candidate biomarkers in patients with heart failure.

journal_name

Heart Fail Rev

journal_title

Heart failure reviews

authors

Rocchiccioli JP,McMurray JJ,Dominiczak AF

doi

10.1007/s10741-008-9123-9

subject

Has Abstract

pub_date

2010-07-01 00:00:00

pages

251-73

issue

4

eissn

1382-4147

issn

1573-7322

journal_volume

15

pub_type

杂志文章,评审
  • Erythropoietin: a future therapy for failing hearts?

    abstract::Recently, it has been suggested that erythropoietin may be useful in the treatment of cardiovascular disease, particularly heart failure. This may be by improving microvascular blood supply and ventricular function through prevention of apoptosis and angiogenesis. Promising results were seen in animals but the few, li...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-011-9288-5

    authors: Tilling L,Clapp B

    更新日期:2012-05-01 00:00:00

  • Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions.

    abstract::Heart failure is a complex clinical syndrome associated with a significant morbidity and mortality burden. Reductions in left ventricular (LV) function trigger adaptive mechanisms, leading to structural changes within the LV and the potential development of dyssynchronous ventricular activation. This is the substrate ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-018-9734-8

    authors: Sieniewicz BJ,Gould J,Porter B,Sidhu BS,Teall T,Webb J,Carr-White G,Rinaldi CA

    更新日期:2019-01-01 00:00:00

  • Stem cells in the diabetic infarcted heart.

    abstract::Diabetes mellitus is one of the leading causes of death, and the majority of these deaths are associated with cardiovascular diseases. Development and progression of myocardial infarction leading to heart failure is much more complex and multifactorial in diabetics compared with non-diabetics. Despite significant adva...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-010-9172-8

    authors: Glass CE,Singal PK,Singla DK

    更新日期:2010-11-01 00:00:00

  • Clinical characteristics, demographics and prognosis of transient left ventricular apical ballooning syndrome.

    abstract:BACKGROUND:Transient left ventricular apical ballooning syndrome also called Tako-Tsubo cardiomyopathy is defined as a syndrome consisting of stress induced apical ballooning of the left ventricle and normal coronary arteries. The majority of the published reports are case reports or case series with a small number of ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,meta分析

    doi:10.1007/s10741-005-8555-8

    authors: Donohue D,Movahed MR

    更新日期:2005-12-01 00:00:00

  • Beta-blockers in heart failure: are pharmacological differences clinically important?

    abstract::Beta-blockers are not an homogeneous group of agents. Only three beta-blockers, carvedilol, bisoprolol and metoprolol succinate, have had favorable effects on prognosis in controlled clinical trials in the patients with chronic heart failure. However, pharmacological differences exist between them. Metoprolol and biso...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1023/B:HREV.0000046367.99002.a4

    authors: Metra M,Cas LD,di Lenarda A,Poole-Wilson P

    更新日期:2004-04-01 00:00:00

  • Anticoagulation in heart failure: current status and future direction.

    abstract::Despite therapeutic advances, patients with worsening heart failure (HF) requiring hospitalization have unacceptably high post-discharge mortality and re-admission rates soon after discharge. Evidence suggests a hypercoagulable state is present in patients with HF. Although thromboembolism as a direct consequence of H...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9343-x

    authors: Gheorghiade M,Vaduganathan M,Fonarow GC,Greene SJ,Greenberg BH,Liu PP,Massie BM,Mehra MR,Metra M,Zannad F,Cleland JG,van Veldhuisen DJ,Shah AN,Butler J

    更新日期:2013-11-01 00:00:00

  • Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure.

    abstract::Sympathetic-parasympathetic interaction plays a major role in the evolution and outcome of many cardiovascular disorders. Nonetheless, a thorough understanding of this relationship and of its potential implications for prognosis and management still escapes many cardiologists. This article reviews the background of sy...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-010-9179-1

    authors: Schwartz PJ,De Ferrari GM

    更新日期:2011-03-01 00:00:00

  • Clinical impact of oral antidiabetic medications in heart failure patients.

    abstract::Heart failure (HF) is a common complication in patients with type 2 diabetes and it is closely associated with high morbidity and mortality rate. The incidence of cardiovascular events in patients with diabetes is related to high levels of glycemia, expressed by increase of HbA1c levels. However, there is little evide...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-018-9669-0

    authors: Palazzuoli A,Ceccarelli E,Ruocco G,Nuti R

    更新日期:2018-05-01 00:00:00

  • The role of myocardial viability in contemporary cardiac practice.

    abstract::Ischemic heart disease (IHD) remains the single most common cause of death worldwide. Ischemic cardiomyopathy is a major sequel of coronary artery disease. The economic health burden of IHD is substantial. In patients with old myocardial infarction (OMI), the extent of viable myocardium (VM) directly affects the short...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-017-9626-3

    authors: Jamiel A,Ebid M,Ahmed AM,Ahmed D,Al-Mallah MH

    更新日期:2017-07-01 00:00:00

  • Prognostic significance of T1 mapping parameters in heart failure with preserved ejection fraction: a systematic review.

    abstract::Heart failure with preserved ejection fraction (HFpEF) accounts for almost one-half of all heart failure (HF) patients and continues to increase in prevalence. While mortality with heart failure with reduced ejection fraction (HFrEF) has decreased over the past few decades with use of evidence-based HFrEF therapy, mor...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-09958-4

    authors: Moustafa A,Khan MS,Alsamman MA,Jamal F,Atalay MK

    更新日期:2020-05-13 00:00:00

  • Devices and interventions for the prevention of adverse outcomes of tachycardia on heart failure.

    abstract::Heart failure (HF) is the leading cause of hospitalization in the USA. Despite advances in pharmacologic management, the incidence of HF is on the rise and survivability is persistently reduced. Sympathetic overdrive is implicated in the pathophysiology of HF, particularly HF with reduced ejection fraction (HFrEF). Ta...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-018-9680-5

    authors: Devgun J,Jobanputra YB,Arustamyan M,Chait R,Ghumman W

    更新日期:2018-07-01 00:00:00

  • Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly.

    abstract::Healing after myocardial infarction (MI) is a well-orchestrated time-dependent process that involves inflammation, tissue repair with extracellular collagen matrix (ECCM) deposition and scar formation, and remodeling of myocardial structure, matrix, vasculature, and function. Rapid early ECCM degradation followed by s...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-008-9090-1

    authors: Jugdutt BI

    更新日期:2008-12-01 00:00:00

  • Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy.

    abstract::Cardiac resynchronization therapy (CRT) has revolutionized the treatment of selected patients with systolic heart failure. It is well recognized, however, that the symptomatic response to and the outcome of CRT is highly variable. The degree of pre-implant mechanical dyssynchrony and the extent as well as the localiza...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-010-9213-3

    authors: Leyva F,Foley PW

    更新日期:2011-05-01 00:00:00

  • Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure.

    abstract::Uric acid, the metabolic mediator of gout and urate renal stones, is associated with increased cardiovascular risk burden. Hyperuricemia is an old emerging metabolic disorder, and interaction among uric acid and cardiovascular diseases has been clearly described. Several illness including hypertension, myocardial infa...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09869-z

    authors: Borghi C,Palazzuoli A,Landolfo M,Cosentino E

    更新日期:2020-01-01 00:00:00

  • Correction to: Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?

    abstract::There was a mistake in Prof. Giuseppe Massimo Claudio Rosano's affiliation. ...

    journal_title:Heart failure reviews

    pub_type: 已发布勘误

    doi:10.1007/s10741-020-10000-w

    authors: Mascolo A,Urbanek K,De Angelis A,Sessa M,Scavone C,Berrino L,Rosano GMC,Capuano A,Rossi F

    更新日期:2020-09-01 00:00:00

  • The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches.

    abstract::This review evaluates the hypothesis that the cardiac effects of amiodarone can be explained-at least partly-by the induction of a local 'hypothyroid-like condition' in the heart. Evidence supporting the hypothesis comprises the observation that amiodarone exerts an inhibitory effect on the binding of T3 to thyroid ho...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-008-9131-9

    authors: Wiersinga WM

    更新日期:2010-03-01 00:00:00

  • Heart transplantation in the young and elderly.

    abstract:INTRODUCTION:Heart transplantation has become an acceptable treatment in pediatric patients with end-stage heart disease and complex congenital heart disease. The liberalization of recipient eligibility criteria, mainly age, along with the expansion of the donor pool has resulted in the acceptable transplantation of ol...

    journal_title:Heart failure reviews

    pub_type: 杂志文章

    doi:10.1023/a:1011406022657

    authors: Laks H,Marelli D,Odim J,Fazio D

    更新日期:2001-09-01 00:00:00

  • Pulmonary hypertension associated with lung diseases and hypoxemia.

    abstract::Pulmonary hypertension that develops in the setting of underlying lung diseases such as COPD or idiopathic pulmonary fibrosis (IPF) is associated with decreased functional status, worsening hypoxemia and quality of life, and increased mortality. This complication of lung disease is complex in its origin and carries a ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-016-9551-x

    authors: Cuttica MJ

    更新日期:2016-05-01 00:00:00

  • The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly.

    abstract::Dilated cardiomyopathy (DCM) is a common debilitating condition with limited therapeutic options besides heart transplantation or palliation. It is characterized by maladaptive remodeling of cardiomyocytes, extracellular collagen matrix (ECCM) and left ventricular (LV) geometry which contributes to further dysfunction...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9300-8

    authors: Butler CR,Jugdutt BI

    更新日期:2012-09-01 00:00:00

  • Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis.

    abstract::In the United States and Europe, approximately 90% of heart failure hospitalizations are due to symptoms and signs of sodium and fluid excess. Congestion is associated with heart failure progression. Venous congestion, rather than a reduced cardiac output, may be the primary hemodynamic factor driving worsening renal ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-011-9248-0

    authors: Costanzo MR,Jessup M

    更新日期:2012-03-01 00:00:00

  • The cytoskeleton and related proteins in the human failing heart.

    abstract::In addition to functional alterations, heart failure has a structural basis as well. This concerns all components of the cardiac myocytes as well as the extracellular space. Proteins of the cardiomyocyte can be subdivided in 5 different categories: 1) Contractile proteins including myosin, actin, tropomyosin and the t...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1023/A:1009813621103

    authors: Kostin S,Hein S,Arnon E,Scholz D,Schaper J

    更新日期:2000-10-01 00:00:00

  • High-density lipoprotein-mediated cardioprotection in heart failure.

    abstract::The prevalence of heart failure (HF), including reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF), has increased significantly worldwide. However, the prognosis and treatment of HF are still not good. Recent studies have demonstrated that high-density lipoprotein (HDL) plays an important role i...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-09916-0

    authors: Jackson AO,Meng J,Tang H,Yin K

    更新日期:2020-01-27 00:00:00

  • Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib.

    abstract::Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by neoplastic transformation of pluripotent cells due to a typical cytogenetic and molecular mutation known as Philadelphia (Ph) chromosome. In 2001, the introduction of the tyrosine kinasis inhibitor (TKI) imatinib as a therapeutic strategy...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-09926-y

    authors: Casavecchia G,Galderisi M,Novo G,Gravina M,Santoro C,Agricola E,Capalbo S,Zicchino S,Cameli M,De Gennaro L,Righini FM,Monte I,Tocchetti CG,Brunetti ND,Cadeddu C,Mercuro G

    更新日期:2020-05-01 00:00:00

  • The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome.

    abstract::Anemia is common in Congestive Heart Failure (CHF) and is associated with an increased mortality, morbidity and progressive renal failure. The most common causes of the anemia in CHF are (1) the associated Chronic Kidney Disease (CKD), which causes depression of erythropoietin (EPO) production in the kidney, and (2) e...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-010-9194-2

    authors: Silverberg DS

    更新日期:2011-11-01 00:00:00

  • Cardiorespiratory fitness in patients with type 2 diabetes: A missing piece of the puzzle.

    abstract::Functional capacity represents an important predictor for cardiovascular and all-cause mortality in patients with diabetes mellitus (DM). Impaired cardiopulmonary fitness is frequently seen in DM patients, and it might partly explain morbidity and mortality in these patients. There are several potential reasons that c...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-10015-3

    authors: Tadic M,Grassi G,Cuspidi C

    更新日期:2020-08-15 00:00:00

  • The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions.

    abstract::Diabetes and heart failure (HF) are both global epidemics with tremendous costs on society with increased rates of HF hospitalizations and worsened prognosis when co-existing, making it a significant "deadly duo." The evidence for pharmacological treatment of HF in patients with type 2 diabetes mellitus (T2DM) stems t...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-018-9685-0

    authors: Ofstad AP,Atar D,Gullestad L,Langslet G,Johansen OE

    更新日期:2018-05-01 00:00:00

  • The use of cognitive behavioral therapy in the treatment of depression for individuals with CHF.

    abstract::Patients diagnosed with CHF have disproportionately high rates of depression. Research has demonstrated significant consequences of depression in patients with CHF including poor quality of life, worse medical adherence and increased health complications, health care utilization, and medical costs. Despite these conse...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-008-9081-2

    authors: O'Hea E,Houseman J,Bedek K,Sposato R

    更新日期:2009-03-01 00:00:00

  • Systolic heart failure in the elderly: optimizing medical management.

    abstract::The aging population with hypertension and coronary artery disease is rapidly increasing worldwide and develops heart failure (HF). A wide range of pharmacotherapeutic drugs are recommended in the HF management guidelines. For the most part, these recommendations are based on the results of studies in the younger popu...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-011-9282-y

    authors: Man JP,Jugdutt BI

    更新日期:2012-09-01 00:00:00

  • The management of conditioned nutritional requirements in heart failure.

    abstract::Patients suffering from congestive heart failure exhibit impaired myocardial energy production, myocyte calcium overload and increased oxidative stress. Nutritional factors known to be important for myocardial energy production, calcium homeostasis and the reduction of oxidative stress, such as thiamine, riboflavin, p...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-006-9195-3

    authors: Allard ML,Jeejeebhoy KN,Sole MJ

    更新日期:2006-03-01 00:00:00

  • Diastolic heart failure: a confusing concept.

    abstract::Descriptions of the pathophysiology of heart failure have gone through a substantial evolution in the last 50 years. It is now recognised that heart failure can occur in the presence and also in the absence of a reduction in left ventricular function. In the former situation, this classically has been described to lea...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9344-9

    authors: Dorhout Mees EJ

    更新日期:2013-07-01 00:00:00